These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25062434)

  • 21. High content screening analysis of phospholipidosis: validation of a 96-well assay with CHO-K1 and HepG2 cells for the prediction of in vivo based phospholipidosis.
    van de Water FM; Havinga J; Ravesloot WT; Horbach GJ; Schoonen WG
    Toxicol In Vitro; 2011 Dec; 25(8):1870-82. PubMed ID: 21651975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation and validation of multiple cell lines and primary mouse macrophages to predict phospholipidosis potential.
    LeCureux L; Cheng CS; Herbst J; Reilly TP; Lehman-McKeeman L; Otieno M
    Toxicol In Vitro; 2011 Dec; 25(8):1934-43. PubMed ID: 21767630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative structure-activity relationship models for predicting drug-induced liver injury based on FDA-approved drug labeling annotation and using a large collection of drugs.
    Chen M; Hong H; Fang H; Kelly R; Zhou G; Borlak J; Tong W
    Toxicol Sci; 2013 Nov; 136(1):242-9. PubMed ID: 23997115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of drugs inducing phospholipidosis by novel in vitro data.
    Muehlbacher M; Tripal P; Roas F; Kornhuber J
    ChemMedChem; 2012 Nov; 7(11):1925-34. PubMed ID: 22945602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimizing predictive performance of CASE Ultra expert system models using the applicability domains of individual toxicity alerts.
    Chakravarti SK; Saiakhov RD; Klopman G
    J Chem Inf Model; 2012 Oct; 52(10):2609-18. PubMed ID: 22947043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishment of an in silico phospholipidosis prediction method using descriptors related to molecular interactions causing phospholipid-compound complex formation.
    Haranosono Y; Nemoto S; Kurata M; Sakaki H
    J Toxicol Sci; 2016 Apr; 41(2):321-8. PubMed ID: 26961617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for the drug-phospholipid interaction: correlation to phospholipidosis.
    Alakoskela JM; Vitovic P; Kinnunen PK
    ChemMedChem; 2009 Aug; 4(8):1224-51. PubMed ID: 19551800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromatography approaches for early screening of the phospholipidosis-inducing potential of pharmaceuticals.
    Jiang Z; Reilly J
    J Pharm Biomed Anal; 2012 Mar; 61():184-90. PubMed ID: 22200505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydrophilic interaction chromatography with a focus on the drug-phosphate interaction in drug screening to determine the phospholipidosis induction risk.
    Okamoto H; Hamaguchi R; Kuroda Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Apr; 1051():33-40. PubMed ID: 28285021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure based model for the prediction of phospholipidosis induction potential of small molecules.
    Sun H; Shahane S; Xia M; Austin CP; Huang R
    J Chem Inf Model; 2012 Jul; 52(7):1798-805. PubMed ID: 22725677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of the health effects of chemicals in humans: I. QSAR estimation of the maximum recommended therapeutic dose (MRTD) and no effect level (NOEL) of organic chemicals based on clinical trial data.
    Matthews EJ; Kruhlak NL; Benz RD; Contrera JF
    Curr Drug Discov Technol; 2004 Jan; 1(1):61-76. PubMed ID: 16472220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization and validation of an in silico toxicology model to predict the mutagenic potential of drug impurities.
    Valerio LG; Cross KP
    Toxicol Appl Pharmacol; 2012 May; 260(3):209-21. PubMed ID: 22426359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for phospholipidosis induced by central nervous drugs: comparing the predictivity of an in vitro assay to high throughput in silico assays.
    Mesens N; Steemans M; Hansen E; Verheyen GR; Van Goethem F; Van Gompel J
    Toxicol In Vitro; 2010 Aug; 24(5):1417-25. PubMed ID: 20430096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A role for lysosomal phospholipase A2 in drug induced phospholipidosis.
    Abe A; Hiraoka M; Shayman JA
    Drug Metab Lett; 2007 Jan; 1(1):49-53. PubMed ID: 19356018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting the Risk of Phospholipidosis with in Silico Models and an Image-Based in Vitro Screen.
    Fusani L; Brown M; Chen H; Ahlberg E; Noeske T
    Mol Pharm; 2017 Dec; 14(12):4346-4352. PubMed ID: 29077420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro assays and biomarkers for drug-induced phospholipidosis.
    Monteith DK; Morgan RE; Halstead B
    Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):687-96. PubMed ID: 17014389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
    Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative Assessment of Drug Delivery to Tissues and Association with Phospholipidosis: A Case Study with Two Structurally Related Diamines in Development.
    Loryan I; Hoppe E; Hansen K; Held F; Kless A; Linz K; Marossek V; Nolte B; Ratcliffe P; Saunders D; Terlinden R; Wegert A; Welbers A; Will O; Hammarlund-Udenaes M
    Mol Pharm; 2017 Dec; 14(12):4362-4373. PubMed ID: 29099189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-induced phospholipidosis caused by combinations of common drugs in vitro.
    Glock M; Muehlbacher M; Hurtig H; Tripal P; Kornhuber J
    Toxicol In Vitro; 2016 Sep; 35():139-48. PubMed ID: 27221059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computational derivation of structural alerts from large toxicology data sets.
    Ahlberg E; Carlsson L; Boyer S
    J Chem Inf Model; 2014 Oct; 54(10):2945-52. PubMed ID: 25275755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.